<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="brief-report" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2022.872126</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Brief Research Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Physical activity and risk of multiple sclerosis: A Mendelian randomization study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Chunyu</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1936915"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Junyu</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1140591"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Tianmi</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1514848"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiao</surname>
<given-names>Yi</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1514822"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Qirui</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1870627"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Shang</surname>
<given-names>Huifang</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/124907"/>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>Department of Neurology, Laboratory of Neurodegenerative Disorders, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Pamela Ann McCombe, The University of Queensland, Australia</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Zhong Pei, First Affiliated Hospital, Sun Yat-Sen University, China; Dongsheng Fan, Peking University Third Hospital, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Huifang Shang, <email xlink:href="mailto:hfshang2002@126.com">hfshang2002@126.com</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Multiple Sclerosis and Neuroimmunology, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>09</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>872126</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>02</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>09</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Li, Lin, Yang, Xiao, Jiang and Shang</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Li, Lin, Yang, Xiao, Jiang and Shang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Multiple evidence from epidemiological studies has suggested association between physical activity and risk of multiple sclerosis (MS). However, the conclusion was still controversial between studies, and whether the association was causal or confounded is elusive. To evaluate the role of physical activity with different intensities in the risk of MS, we first estimated their genetic correlation, and then conducted two-sample and multivariable Mendelian randomization analyses based on summary statistics from previous large genome-wide association studies. A significant genetic correlation was identified between moderate physical activity and the risk of MS (genetic correlation: -0.15, SE=0.05, P=2.9E-03). Meanwhile, higher moderate physical activity was significantly associated with a reduced risk of MS (OR:0.87, 95% CI:0.80-0.96, P=3.45E-03). Such association was further verified using summary statistics from another study on overall physical activity (OR:0.36, 95% CI:0.17-0.76, P=6.82E-03). The results were robust under all sensitivity analyses. Current results suggested moderate physical activity could reduce the risk of MS. These findings help better understand the role of physical activity in MS, and provide some lifestyle recommendations for individuals susceptible to MS.</p>
</abstract>
<kwd-group>
<kwd>physical activity</kwd>
<kwd>multiple sclerosis</kwd>
<kwd>Mendelian randomization</kwd>
<kwd>genetic correlation</kwd>
<kwd>causation</kwd>
</kwd-group>
<contract-num rid="cn001">81871000, 81901294</contract-num>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<counts>
<fig-count count="2"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="30"/>
<page-count count="7"/>
<word-count count="3225"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Multiple sclerosis (MS) is a devastating neurodegenerative disorder which affects the brain and spinal cord, slowly robbing patients of their physical mobility, vision and balance (<xref ref-type="bibr" rid="B1">1</xref>). Several factors could influence the susceptibility of MS, like genetic background and environmental factors such as smoking and vitamin D deficiency (<xref ref-type="bibr" rid="B2">2</xref>). Identifying risk factors for MS could help better understand the pathogenesis, and provide care and therapeutic strategies for patients and clinicians.</p>
<p>Physical activity can improve body health and has been suggested to be beneficial in several neurodegenerative disorders including MS. A previous case-control study comprising 628 men with MS and 6187 matched controls identified that the patients had lower physical working capacity in adolescence compared with controls (OR=0.94, 95% CI: 0.89-0.99, P=0.026) (<xref ref-type="bibr" rid="B3">3</xref>). Another study among 1904 MS cases and 3694 controls identified vigorous physical activity was inversely associated with the risk of MS (OR=0.74, 95% CI: 0.63-0.87, P&lt;0.001), suggesting the potential protective role of physical activity against MS (<xref ref-type="bibr" rid="B4">4</xref>). Meanwhile, physical activity was shown to significantly reduce symptoms such as fatigue in patients with MS (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). However, too aggressive physical activity might also bring on severe fatigue and too much stress in the muscles, which might be harmful to patients with MS. Additionally, a previous case-control study investigating lifestyle factors and risk of MS among 80 cases and 160 controls reported no significant difference in physical activity level between MS patients and controls (<xref ref-type="bibr" rid="B7">7</xref>). Another study in two prospective cohorts found that women in the highest physical activity quartile had a 27% reduced rate of MS (RR=0.73, 95% CI: 0.55-0.98, P=0.08), but the trend was not present in 6-year lagged analyses, suggesting the reduced physical activity might be in response to subclinical MS (<xref ref-type="bibr" rid="B8">8</xref>). And individuals with MS might even be more physically active than controls before diagnosis of MS in a previous case-control study of 200 newly diagnosed MS patients and 202 matched controls (OR=2.3, 95% CI:1.4-3.9) (<xref ref-type="bibr" rid="B9">9</xref>). Nevertheless, such observational studies might be biased by unavoidable confounding factors and a relatively small sample size. It could not be determined whether worsened motor symptoms in MS led to less physical activity or vice versa. Therefore, whether physical activity has a beneficial role in the susceptibility of MS is still elusive.</p>
<p>Genetic data has provided valuable insights into the causes and risk factors of complex diseases (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>). In the current study, we performed two-sample Mendelian randomization (MR) analysis to explore the causal role of physical activity in the risk of MS. With valid instrumental variables, the MR approach is less susceptible to reverse causation or confounding factors which may influence interpretations of results from conventional observational studies. As a result, we identified that moderate physical activity was causally associated with a reduced risk of MS.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Methods</title>
<sec id="s2_1">
<title>Datasets</title>
<p>Exposure data were from a recent GWAS on physical activity among 377,234 participants from the UK Biobank (<xref ref-type="bibr" rid="B12">12</xref>). A touchscreen questionnaire was used to measure physical activity during work and leisure time. Four physical activity phenotypes from this study were analyzed, including self-reported moderate-to-vigorous physical activity (MVPA), self-reported vigorous physical activity (VPA), overall acceleration average (AccAve), and 2-3 days/week or more in doing strenuous sports or other exercises for a duration of 15-30 minutes or greater (SSOE) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>). As a replication, we further analyzed summary data from another GWAS on overall physical activity measured using wrist worn accelerometers (N=91,105) (<xref ref-type="bibr" rid="B13">13</xref>) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>). The overall activity levels were measured by average vector magnitude for each 30-s epoch, which was the recommended variable for activity analysis. Single nucleotide polymorphisms (SNP) with genome-wide significance (P&lt;5E-08) from the original studies were clumped based on the 1,000 Genomes Project linkage disequilibrium (LD) structure. Index SNPs (R<sup>2</sup>&lt;0.001 with any other associated SNP within 10 Mb) with the minimum P value were kept as instrumental variables. Furthermore, we used the PhenoScanner v2 tool to check for variants associated with other phenotypes (P&lt;5E-08) which might affect the risk of MS independent of physical activity (<xref ref-type="bibr" rid="B14">14</xref>).</p>
<p>Summary statistics of outcome were from the largest GWAS on MS involving 47,429 cases and 68,374 controls of European descent (<xref ref-type="bibr" rid="B15">15</xref>). As a replication, we further analyzed summary statistics from another GWAS on MS (N<sub>case</sub>=14,802, N<sub>control</sub>=26,703) (<xref ref-type="bibr" rid="B16">16</xref>). Harmonization was undertaken to rule out strand mismatches and ensure alignment of SNP effect sizes.</p>
</sec>
<sec id="s2_2">
<title>Genetic correlation</title>
<p>We estimated the genetic correlation between physical activity and MS using the LDSC and GNOVA methods with default parameters (<xref ref-type="bibr" rid="B17">17</xref>). The LDSC method quantifies the genetic correlation by exploiting the relationship between association test statistics and LD score expected under polygenicity. GNOVA calculates the genetic correlation based on genetic covariance and variant-based heritabilities, providing powerful statistical inferences that are robust to LD and sample overlap. All the SNPs in physical activity and MS together with reference data derived from the 1000 Genomes Project European population were utilized. A P value below 0.01 (0.05/5) was considered statistically significant after the Bonferroni correction.</p>
</sec>
<sec id="s2_3">
<title>Mendelian randomization analysis</title>
<p>We hypothesized that physical activity as a protective factor could causally decrease the risk of MS, and the following assumptions were satisfied: the instrumental variables are associated with physical activity; the instrumental variables are not associated with confounders; the instrumental variables are associated with MS through physical activity (namely horizontal pleiotropy should not be present) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref>).</p>
<p>To evaluate the causative effect of physical activity on the risk of MS, we performed a two-sample MR analysis using the random effects inverse variance weighted (IVW) method, which is most widely used in MR studies and could provide robust causal estimates. A P value below 0.01 (0.05/5) was considered statistically significant after the Bonferroni correction. We further verified the results using the weighted median method, which generally has greater power with a positive causal effect. In addition, we conducted comprehensive sensitivity analyses to estimate potential violations of the model assumptions in the MR analysis. We conducted Mendelian randomization pleiotropy residual sum and outlier (MR-PRESSO) analysis and leave-one-out analysis to detect outlier instrumental variables. Outlier instrument variables identified by the MR-PRESSO analysis were removed step-by-step to reduce the effect of horizontal pleiotropy. Cochran&#x2019;s Q test was executed to check heterogeneity across the individual causal effects. MR-Egger regression was performed to evaluate the pleiotropy of instrumental variables. Reverse causal inference with Steiger analysis was conducted to explore whether MS has a causal impact on physical activity. To evaluate the strength of each instrumental variable, we computed the F-statistic of each SNP. The statistical power was calculated using an online tool at <uri xlink:href="http://cnsgenomics.com/shiny/mRnd/">http://cnsgenomics.com/shiny/mRnd/</uri>. The statistical analyses were conducted using R package TwoSampleMR 0.5.5.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<p>We first estimated the genetic correlation between physical activity and the risk of MS. We detected a significant and negative genetic correlation between MS and AccAve (genetic correlation: -0.15, SE=0.05, P=2.9E-03), overall activity (genetic correlation: -0.12, SE=0.04, P=5.3E-03) using the LDSC method (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>). Such association was further verified in the replication stage for AccAve (genetic correlation: -0.12, SE=0.04, P=2.4E-03) and overall activity (genetic correlation: -0.12, SE=0.04, P=4.80E-03). Similar results were identified using the GNOVA method (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Genetic correlation between physical activity and multiple sclerosis. Genetic correlation was estimated using the GNOVA and LDSC methods in the <bold>(A)</bold> discovery and <bold>(B)</bold> replication stages. Error bars indicate 95% confidence intervals. AccAve, overall acceleration average; MVPA, self-reported moderate-to-vigorous physical activity; VPA, self-reported vigorous physical activity; SSOE, strenuous sports or other exercises; OA, overall activity.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-872126-g001.tif"/>
</fig>
<p>Then we analyzed the role of physical activity in the risk of MS using the two-sample MR approach. Results showed that each one standard deviation increase in AccAve (OR=0.87, 95% CI: 0.80-0.96, P=3.45E-03) and MVPA (OR=0.27, 95% CI: 0.14-0.52, P=8.26E-05) was significantly associated with a reduced risk of MS (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;2, 3</bold>
</xref>). Meanwhile, higher overall activity was significantly associated with a reduced risk of MS using summary statistics from another GWAS on physical activity (OR=0.36, 95% CI: 0.17-0.76, P=6.82E-03) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). These associations were further verified using the weighted median method (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). In the replication stage, higher MVPA (OR=0.28, 95% CI: 0.15-0.53, P=9.02E-05) and overall activity (OR=0.26, 95% CI: 0.12-0.59, P=1.14E-03) were significantly associated with reduced risk of MS (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>). In contrast, no association was identified between SSOE, VPA and MS, suggesting too strenuous physical activity might not be protective against the risk of MS (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Forest plot showing results from the Mendelian randomization analysis. Mendelian randomization results were estimated using the inverse variance weighted and weighted median methods in the <bold>(A)</bold> discovery and <bold>(B)</bold> replication stages. Estimates are per 1 standard deviation increase in the trait. AccAve, overall acceleration average; MVPA, self-reported moderate-to-vigorous physical activity; VPA, self-reported vigorous physical activity; SSOE, strenuous sports or other exercises; OA, overall activity.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-872126-g002.tif"/>
</fig>
<p>Furthermore, we performed extensive sensitivity analyses to detect potential violations of the MR model assumptions. No heterogeneity of effects was detected by the Cochran&#x2019;s Q test (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). The F statistics of all the instrumental variables were above 10 (ranging from 29 to 82) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2</bold>
</xref>), indicating valid strength of the instrumental variables. No apparent horizontal pleiotropy was observed as the intercept of MR-Egger was not significantly deviated from zero (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). Meanwhile, no potential instrumental outlier was detected by the MR-PRESSO analysis. The Steiger test suggested correct directionality (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). The leave-one-out results suggest that the causal effect was not driven by a single instrumental variable (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;2-6</bold>
</xref>). Given the type 1 error of 0.05, we had sufficient power (&gt;&#x2009;80%) to detect the association between MVPA, overall activity and MS (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;3</bold>
</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Heterogeneity and horizontal pleiotropy analyses between physical activity and multiple sclerosis.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">stage</th>
<th valign="top" align="center">exposure trait</th>
<th valign="top" colspan="3" align="center">Heterogeneity test</th>
<th valign="top" colspan="3" align="center">Horizontal pleiotropy</th>
<th valign="top" align="center">MR-PRESSO P value</th>
<th valign="top" colspan="2" align="center">Steiger test</th>
</tr>
<tr>
<th valign="top" align="center"/>
<th valign="top" align="center"/>
<th valign="top" align="center">Q</th>
<th valign="top" align="center">Q df</th>
<th valign="top" align="center">P value</th>
<th valign="top" align="center">Egger intercept</th>
<th valign="top" align="center">SE</th>
<th valign="top" align="center">P</th>
<th valign="top" align="center"/>
<th valign="top" align="center">correct direction</th>
<th valign="top" align="center">P value</th>
<th valign="top" align="center"/>
<th valign="top" align="center"/>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" rowspan="5" align="left">discovery</td>
<td valign="top" align="left">AccAve</td>
<td valign="top" align="center">3.64</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">0.30</td>
<td valign="top" align="center">0.09</td>
<td valign="top" align="center">0.06</td>
<td valign="top" align="center">0.30</td>
<td valign="top" align="center">0.35</td>
<td valign="top" align="center">TRUE</td>
<td valign="top" align="center">5.86E-05</td>
</tr>
<tr>
<td valign="top" align="left">MVPA</td>
<td valign="top" align="center">19.89</td>
<td valign="top" align="center">17</td>
<td valign="top" align="center">0.28</td>
<td valign="top" align="center">0.04</td>
<td valign="top" align="center">0.03</td>
<td valign="top" align="center">0.18</td>
<td valign="top" align="center">0.31</td>
<td valign="top" align="center">TRUE</td>
<td valign="top" align="center">4.62E-11</td>
</tr>
<tr>
<td valign="top" align="left">VPA</td>
<td valign="top" align="center">3.67</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">0.60</td>
<td valign="top" align="center">-0.01</td>
<td valign="top" align="center">0.06</td>
<td valign="top" align="center">0.88</td>
<td valign="top" align="center">0.62</td>
<td valign="top" align="center">TRUE</td>
<td valign="top" align="center">2.00E-09</td>
</tr>
<tr>
<td valign="top" align="left">SSOE</td>
<td valign="top" align="center">16.14</td>
<td valign="top" align="center">12</td>
<td valign="top" align="center">0.18</td>
<td valign="top" align="center">0.03</td>
<td valign="top" align="center">0.04</td>
<td valign="top" align="center">0.48</td>
<td valign="top" align="center">0.18</td>
<td valign="top" align="center">TRUE</td>
<td valign="top" align="center">5.50E-14</td>
</tr>
<tr>
<td valign="top" align="left">OA</td>
<td valign="top" align="center">2.29</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.32</td>
<td valign="top" align="center">0.08</td>
<td valign="top" align="center">0.07</td>
<td valign="top" align="center">0.45</td>
<td valign="top" align="center">n.a.</td>
<td valign="top" align="center">TRUE</td>
<td valign="top" align="center">7.20E-15</td>
</tr>
<tr>
<td valign="top" rowspan="5" align="left">replication</td>
<td valign="top" align="left">AccAve</td>
<td valign="top" align="center">11.59</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">0.05</td>
<td valign="top" align="center">-0.05</td>
<td valign="top" align="center">0.06</td>
<td valign="top" align="center">0.47</td>
<td valign="top" align="center">0.04</td>
<td valign="top" align="center">TRUE</td>
<td valign="top" align="center">1.81E-01</td>
</tr>
<tr>
<td valign="top" align="left">MVPA</td>
<td valign="top" align="center">19.44</td>
<td valign="top" align="center">17</td>
<td valign="top" align="center">0.30</td>
<td valign="top" align="center">0.04</td>
<td valign="top" align="center">0.03</td>
<td valign="top" align="center">0.23</td>
<td valign="top" align="center">0.30</td>
<td valign="top" align="center">TRUE</td>
<td valign="top" align="center">4.21E-02</td>
</tr>
<tr>
<td valign="top" align="left">VPA</td>
<td valign="top" align="center">3.68</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">0.60</td>
<td valign="top" align="center">-0.01</td>
<td valign="top" align="center">0.06</td>
<td valign="top" align="center">0.88</td>
<td valign="top" align="center">0.62</td>
<td valign="top" align="center">TRUE</td>
<td valign="top" align="center">1.65E-03</td>
</tr>
<tr>
<td valign="top" align="left">SSOE</td>
<td valign="top" align="center">14.94</td>
<td valign="top" align="center">12</td>
<td valign="top" align="center">0.24</td>
<td valign="top" align="center">1.43E-04</td>
<td valign="top" align="center">0.03</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center">0.26</td>
<td valign="top" align="center">TRUE</td>
<td valign="top" align="center">4.53E-04</td>
</tr>
<tr>
<td valign="top" align="left">OA</td>
<td valign="top" align="center">0.06</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0.81</td>
<td valign="top" align="center">n.a.</td>
<td valign="top" align="center">n.a.</td>
<td valign="top" align="center">n.a.</td>
<td valign="top" align="center">n.a.</td>
<td valign="top" align="center">TRUE</td>
<td valign="top" align="center">2.38E-06</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Cochran&#x2019;s Q statistic was used to detect heterogeneity about the inverse variance weighted estimate in the Mendelian randomization analysis. Q, Cochran&#x2019;s Q test estimate; df, Cochran&#x2019;s Q test degrees of freedom; SE, standard error; AccAve, overall acceleration average; PA, physical activity; MVPA, moderate-to-vigorous PA; VPA, vigorous PA; SSOE, strenuous sports or other exercises; OA, overall activity.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Lastly, we used the PhenoScanner tool to check if the SNPs used as instrumental variables in the MR analysis were associated with other phenotypes. Several SNPs were associated with body mass index (BMI) which was suggested to affect the risk of MS (<xref ref-type="bibr" rid="B18">18</xref>) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;4</bold>
</xref>). Therefore, we further performed multivariable MR to elucidate the causal relationship between physical activity and MS adjusting potential pleiotropy due to BMI. The summary data of BMI was obtained from GWAS published by the Genetic Investigation of Anthropometric Traits (GIANT) consortium (<xref ref-type="bibr" rid="B19">19</xref>). As a result, a nominal significant association was still identified between moderate physical activity and MS in the multivariable MR analyses adjusting for BMI (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>).</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Mendelian randomization estimates between physical activity and multiple sclerosis adjusting for body mass index.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">stage</th>
<th valign="top" align="center">exposure trait</th>
<th valign="top" align="center">beta</th>
<th valign="top" align="center">SE</th>
<th valign="top" align="center">P value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" rowspan="5" align="left">discovery</td>
<td valign="top" align="left">AccAve</td>
<td valign="top" align="center">-0.11</td>
<td valign="top" align="center">0.05</td>
<td valign="top" align="center">0.017</td>
</tr>
<tr>
<td valign="top" align="left">MVPA</td>
<td valign="top" align="center">-1.77</td>
<td valign="top" align="center">0.50</td>
<td valign="top" align="center">4.25E-04</td>
</tr>
<tr>
<td valign="top" align="left">VPA</td>
<td valign="top" align="center">-1.19</td>
<td valign="top" align="center">1.39</td>
<td valign="top" align="center">0.389</td>
</tr>
<tr>
<td valign="top" align="left">SSOE</td>
<td valign="top" align="center">0.49</td>
<td valign="top" align="center">1.02</td>
<td valign="top" align="center">0.630</td>
</tr>
<tr>
<td valign="top" align="left">overall activity</td>
<td valign="top" align="center">-0.85</td>
<td valign="top" align="center">0.41</td>
<td valign="top" align="center">0.036</td>
</tr>
<tr>
<td valign="top" rowspan="5" align="left">replication</td>
<td valign="top" align="left">AccAve</td>
<td valign="top" align="center">-0.10</td>
<td valign="top" align="center">0.05</td>
<td valign="top" align="center">0.030</td>
</tr>
<tr>
<td valign="top" align="left">MVPA</td>
<td valign="top" align="center">-1.99</td>
<td valign="top" align="center">0.61</td>
<td valign="top" align="center">0.001</td>
</tr>
<tr>
<td valign="top" align="left">VPA</td>
<td valign="top" align="center">-1.19</td>
<td valign="top" align="center">1.39</td>
<td valign="top" align="center">0.389</td>
</tr>
<tr>
<td valign="top" align="left">SSOE</td>
<td valign="top" align="center">0.84</td>
<td valign="top" align="center">0.99</td>
<td valign="top" align="center">0.399</td>
</tr>
<tr>
<td valign="top" align="left">overall activity</td>
<td valign="top" align="center">-0.85</td>
<td valign="top" align="center">0.41</td>
<td valign="top" align="center">0.036</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>AccAve, overall acceleration average; PA, physical activity; MVPA, moderate-to-vigorous PA; VPA, vigorous PA; SSOE, strenuous sports or other exercises.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Previous epidemiological studies have suggested physical activity was beneficial against susceptibility and symptoms of MS, but such a conclusion was still controversial across studies. Meanwhile, unmeasured confounding factors in clinical studies could potentially bias the association evidence. Two previous MR studies analyzed the role of physical activity in the risk of MS (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>), but got different results. However, the sample sizes in these two studies were much smaller, and only single type of physical activity was analyzed without adjusting for potential pleiotropy from other traits. In the current study, we systematically investigated the causative role of physical activity with different intensities in the risk of MS using the genetic correlation, two-sample and multivariable MR approaches. We identified a significant negative genetic correlation between physical activity and MS. Meanwhile, moderate physical activity was causally associated with a lower risk of MS. These findings provided a better understanding of the role of physical activity in MS, and had clinical implications for patients and caregivers.</p>
<p>The promotion of an active lifestyle has been suggested in the treatment of a broad range of diseases that are tightly linked to metabolic and immune-mediated disarrangement, including autoimmune diseases such as MS (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>). Though most epidemiological studies have supported the protective role of physical activity in the risk of MS (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>), contradictory results have also been reported (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B9">9</xref>). Using the MR approach, our results demonstrated the protective effect of moderate physical activity against MS. Similarly, previous studies showed that aerobic exercise could improve mood and reduce fatigue in patients with MS (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>), suggesting the beneficial role of physical activity in the MS pathogenesis. The exact mechanism of such protective mechanism is still not well understood. One possible explanation is that physical activity could function as potential immunomodulatory therapy, targeting innate signaling mechanisms to modulate MS symptoms (<xref ref-type="bibr" rid="B26">26</xref>). Physical activity leads to a significant elevation in T-regulatory cells, decreased immunoglobulin secretion and produces a shift in the Th1/Th2 balance, and is shown to reduce inflammatory events in patients and animal models of inflammatory diseases (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>). Meanwhile, physical activity could promote the release of IL-6 from muscles, which functions as a myokine and has been suggested to induce an anti-inflammatory response through IL-10 secretion and IL-1&#x3b2; inhibition (<xref ref-type="bibr" rid="B23">23</xref>). Additionally, exercise-induced systemic elevation of hormones, such as cortisol and epinephrine, inhibits the secretion of pro-inflammatory tumor necrosis factor (TNF)-&#x3b1; by monocytes. Furthermore, exercise might exert a protective role by affecting the modulation of immune factors and stress hormones in MS (<xref ref-type="bibr" rid="B29">29</xref>). These observations suggested physical activity might affect the pathogenesis of MS by modulating inflammation. Moreover, physical activity could mediate the expression of neuroactive proteins, such as neuroprotective insulin-like growth factor-I, and other neurotrophic factors like brain-derived neurotrophic factor (BDNF) which might be related to neuronal survival (<xref ref-type="bibr" rid="B30">30</xref>). Notably, compared with moderate physical activity, vigorous physical activity was not associated with the risk of MS based on current results. Consistent with this finding, a majority of MS patients feel high-temperature intolerance which might be related to temporary exacerbation of clinical manifestations. Vigorous physical activity might increase the core body temperature, and thus bringing harm to patients with MS. Therefore, too light or too aggressive physical activity both were not beneficial for MS. Further studies investigating physical activity in MS could pay attention to the effect of excessive levels of physical activity.</p>
<p>There were also some limitations worth mentioning in the current study. First, only a limited number of instrumental variables were significant in the GWAS of physical activity, which was susceptible to bias. The potential causal associations in the current study should be interpreted with caution, and further replications in well-power studies were still warranted. Second, the variance explained by the instrumental variables of the exposures such as SSOE and VPA was moderate, which limited the power to detect weaker causal associations. Replication based on summary statistics from future GWAS with a larger sample size was still necessary. Third, though physical activities with different intensities were examined, current GWAS did not differentiate between types of physical activity, like swimming and running. Considering that different types of physical activity might have different benefits and involve different parts of the body, further investigation into subtypes of physical activities might provide additional insights.</p>
<p>In conclusion, based on results from the genetic correlation and MR analyses, we demonstrated that moderate physical activity could causally decrease the risk of MS. These results could help better understand the role of physical activity in the pathogenesis of MS, and provided some lifestyle recommendations for individuals susceptible to MS.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author contributions</title>
<p>(1) Research project, A. Conception, B. Organization, C. Execution. (2) Statistical Analysis, A. Design, B. Execution, C. Review and Critique. (3) Manuscript, A. Writing of the First Draft, B. Review and Critique. CL, 1A, 1C, 2A, 2B, 2C, 3A. JL, 2B, 3A, 3B. TY, 3B. YX, 3B. QJ, 3B. HS, 1B, 2C, 3B. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s7" sec-type="funding-information">
<title>Funding</title>
<p>This research was supported by the funding of the National Key Research and Development Program of China (Grant No. 2021YFC2501200), the Sichuan Science and Technology Program (Grant No. 2022ZDZX0023 and 2021YJ0415) and the National Natural Science Foundation of China (Grant No. 81901294 and 81871000).</p>
</sec>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<sec id="s10" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2022.872126/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2022.872126/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.pdf" id="SM1" mimetype="application/pdf"/>
<supplementary-material xlink:href="DataSheet_2.pdf" id="SM2" mimetype="application/pdf"/>
</sec>
<sec id="s11">
<title>Abbreviations</title>
<p>AccAve, overall acceleration average; BMI, body mass index; GWAS, genome-wide association study; IVW, inverse variance weighted; LD, linkage disequilibrium; MR, Mendelian randomization; MS, multiple sclerosis; MVPA, moderate-to-vigorous physical activity; SSOE, 2-3 days/week or more in doing strenuous sports or other exercises for a duration of 15-30 minutes or greater; SNP, single nucleotide polymorphism; VPA, self-reported vigorous physical activity.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Owens</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Multiple sclerosis</article-title>. <source>Nature</source> (<year>2016</year>) <volume>540</volume>(<issue>7631</issue>):<page-range>S1&#x2013;S</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/540S1a</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Disanto</surname> <given-names>G</given-names>
</name>
<name>
<surname>Morahan</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Ramagopalan</surname> <given-names>SV</given-names>
</name>
</person-group>. <article-title>Multiple sclerosis: risk factors and their interactions</article-title>. <source>CNS neurological Disord Drug Targets</source> (<year>2012</year>) <volume>11</volume>(<issue>5</issue>):<page-range>545&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/187152712801661266</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gunnarsson</surname> <given-names>M</given-names>
</name>
<name>
<surname>Udumyan</surname> <given-names>R</given-names>
</name>
<name>
<surname>Bahmanyar</surname> <given-names>S</given-names>
</name>
<name>
<surname>Nilsag&#xe5;rd</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Montgomery</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Characteristics in childhood and adolescence associated with future multiple sclerosis risk in men: cohort study</article-title>. <source>Eur J Neurol</source> (<year>2015</year>) <volume>22</volume>(<issue>7</issue>):<page-range>1131&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/ene.12718</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wesnes</surname> <given-names>K</given-names>
</name>
<name>
<surname>Myhr</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Riise</surname> <given-names>T</given-names>
</name>
<name>
<surname>Cortese</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pugliatti</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bostr&#xf6;m</surname> <given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>Physical activity is associated with a decreased multiple sclerosis risk: The EnvIMS study</article-title>. <source>Multiple sclerosis (Houndmills Basingstoke England)</source> (<year>2018</year>) <volume>24</volume>(<issue>2</issue>):<page-range>150&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/1352458517694088</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Razazian</surname> <given-names>N</given-names>
</name>
<name>
<surname>Kazeminia</surname> <given-names>M</given-names>
</name>
<name>
<surname>Moayedi</surname> <given-names>H</given-names>
</name>
<name>
<surname>Daneshkhah</surname> <given-names>A</given-names>
</name>
<name>
<surname>Shohaimi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Mohammadi</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>The impact of physical exercise on the fatigue symptoms in patients with multiple sclerosis: a systematic review and meta-analysis</article-title>. <source>BMC Neurol</source> (<year>2020</year>) <volume>20</volume>(<issue>1</issue>):<fpage>93</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12883-020-01654-y</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Motl</surname> <given-names>RW</given-names>
</name>
<name>
<surname>Arnett</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Barwick</surname> <given-names>FH</given-names>
</name>
<name>
<surname>Ahlstrom</surname> <given-names>B</given-names>
</name>
<name>
<surname>Stover</surname> <given-names>EJ</given-names>
</name>
</person-group>. <article-title>Worsening of symptoms is associated with lower physical activity levels in individuals with multiple sclerosis</article-title>. <source>Multiple sclerosis (Houndmills Basingstoke England)</source> (<year>2008</year>) <volume>14</volume>(<issue>1</issue>):<page-range>140&#x2013;2</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/1352458507079126</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halawani</surname> <given-names>AT</given-names>
</name>
<name>
<surname>Zeidan</surname> <given-names>ZA</given-names>
</name>
<name>
<surname>Kareem</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Alharthi</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Almalki</surname> <given-names>HA</given-names>
</name>
</person-group>. <article-title>Sociodemographic, environmental and lifestyle risk factors for multiple sclerosis development in the Western region of Saudi arabia. a matched case control study</article-title>. <source>Saudi Med J</source> (<year>2018</year>) <volume>39</volume>(<issue>8</issue>):<page-range>808&#x2013;14</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.15537/smj.2018.8.22864</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dorans</surname> <given-names>KS</given-names>
</name>
<name>
<surname>Massa</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chitnis</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ascherio</surname> <given-names>A</given-names>
</name>
<name>
<surname>Munger</surname> <given-names>KL</given-names>
</name>
</person-group>. <article-title>Physical activity and the incidence of multiple sclerosis</article-title>. <source>Neurology</source> (<year>2016</year>) <volume>87</volume>(<issue>17</issue>):<page-range>1770&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1212/wnl.0000000000003260</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghadirian</surname> <given-names>P</given-names>
</name>
<name>
<surname>Dadgostar</surname> <given-names>B</given-names>
</name>
<name>
<surname>Azani</surname> <given-names>R</given-names>
</name>
<name>
<surname>Maisonneuve</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>A case-control study of the association between socio-demographic, lifestyle and medical history factors and multiple sclerosis</article-title>. <source>Can J Public Health = Rev Can sante publique</source> (<year>2001</year>) <volume>92</volume>(<issue>4</issue>):<page-range>281&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/bf03404961</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>T</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Fujita</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>CMC: A consensus multi-view clustering model for predicting alzheimer&#x2019;s disease progression</article-title>. <source>Comput Methods programs biomedicine</source> (<year>2021</year>) <volume>199</volume>:<elocation-id>105895</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cmpb.2020.105895</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>C</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Shang</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>COVID-19 and risk of neurodegenerative disorders: A mendelian randomization study</article-title>. <source>Trans Psychiatry</source> (<year>2022</year>) <volume>12</volume>(<issue>1</issue>):<fpage>283</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41398-022-02052-3</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klimentidis</surname> <given-names>YC</given-names>
</name>
<name>
<surname>Raichlen</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Bea</surname> <given-names>J</given-names>
</name>
<name>
<surname>Garcia</surname> <given-names>DO</given-names>
</name>
<name>
<surname>Wineinger</surname> <given-names>NE</given-names>
</name>
<name>
<surname>Mandarino</surname> <given-names>LJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Genome-wide association study of habitual physical activity in over 377,000 UK biobank participants identifies multiple variants including CADM2 and APOE</article-title>. <source>Int J Obes (2005)</source> (<year>2018</year>) <volume>42</volume>(<issue>6</issue>):<page-range>1161&#x2013;76</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41366-018-0120-3</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doherty</surname> <given-names>A</given-names>
</name>
<name>
<surname>Smith-Byrne</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ferreira</surname> <given-names>T</given-names>
</name>
<name>
<surname>Holmes</surname> <given-names>MV</given-names>
</name>
<name>
<surname>Holmes</surname> <given-names>C</given-names>
</name>
<name>
<surname>Pulit</surname> <given-names>SL</given-names>
</name>
<etal/>
</person-group>. <article-title>GWAS identifies 14 loci for device-measured physical activity and sleep duration</article-title>. <source>Nat Commun</source> (<year>2018</year>) <volume>9</volume>(<issue>1</issue>):<fpage>5257</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-018-07743-4</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamat</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Blackshaw</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Young</surname> <given-names>R</given-names>
</name>
<name>
<surname>Surendran</surname> <given-names>P</given-names>
</name>
<name>
<surname>Burgess</surname> <given-names>S</given-names>
</name>
<name>
<surname>Danesh</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations</article-title>. <source>Bioinf (Oxford England)</source> (<year>2019</year>) <volume>35</volume>(<issue>22</issue>):<page-range>4851&#x2013;3</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bioinformatics/btz469</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<collab>International Multiple Sclerosis Genetics Consortium</collab>
</person-group>. <article-title>Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility</article-title>. <source>Science</source> (<year>2019</year>) <volume>365</volume>(<issue>6460</issue>):<elocation-id>eaav7188</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.aav7188</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beecham</surname> <given-names>AH</given-names>
</name>
<name>
<surname>Patsopoulos</surname> <given-names>NA</given-names>
</name>
<name>
<surname>Xifara</surname> <given-names>DK</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>MF</given-names>
</name>
<name>
<surname>Kemppinen</surname> <given-names>A</given-names>
</name>
<name>
<surname>Cotsapas</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis</article-title>. <source>Nat Genet</source> (<year>2013</year>) <volume>45</volume>(<issue>11</issue>):<page-range>1353&#x2013;60</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ng.2770</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>C</given-names>
</name>
<name>
<surname>Pang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>T</given-names>
</name>
<name>
<surname>Shang</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Shared genetic links between frontotemporal dementia and psychiatric disorders</article-title>. <source>BMC Med</source> (<year>2022</year>) <volume>20</volume>(<issue>1</issue>):<fpage>131</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12916-022-02335-y</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>H&#xf8;glund</surname> <given-names>RAA</given-names>
</name>
<name>
<surname>Meyer</surname> <given-names>HE</given-names>
</name>
<name>
<surname>Stigum</surname> <given-names>H</given-names>
</name>
<name>
<surname>Torkildsen</surname> <given-names>&#xd8;</given-names>
</name>
<name>
<surname>Grytten</surname> <given-names>N</given-names>
</name>
<name>
<surname>Holm&#xf8;y</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Association of body mass index in adolescence and young adulthood and long-term risk of multiple sclerosis: A population-based study</article-title>. <source>Neurology</source> (<year>2021</year>) <volume>97</volume>(<issue>23</issue>):<page-range>e2253&#x2013;e61</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1212/wnl.0000000000012957</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Locke</surname> <given-names>AE</given-names>
</name>
<name>
<surname>Kahali</surname> <given-names>B</given-names>
</name>
<name>
<surname>Berndt</surname> <given-names>SI</given-names>
</name>
<name>
<surname>Justice</surname> <given-names>AE</given-names>
</name>
<name>
<surname>Pers</surname> <given-names>TH</given-names>
</name>
<name>
<surname>Day</surname> <given-names>FR</given-names>
</name>
<etal/>
</person-group>. <article-title>Genetic studies of body mass index yield new insights for obesity biology</article-title>. <source>Nature</source> (<year>2015</year>) <volume>518</volume>(<issue>7538</issue>):<fpage>197</fpage>&#x2013;<lpage>206</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature14177</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>PF</given-names>
</name>
<name>
<surname>Li</surname> <given-names>RZ</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>GX</given-names>
</name>
</person-group>. <article-title>Relationships between accelerometer-measured and multiple sclerosis: a 2-sample mendelian randomization study</article-title>. <source>Neurological sciences: Off J Ital Neurological Soc Ital Soc Clin Neurophysiol</source> (<year>2021</year>) <volume>42</volume>(<issue>8</issue>):<page-range>3337&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10072-020-04953-x</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Xiong</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Larsson</surname> <given-names>SC</given-names>
</name>
</person-group>. <article-title>An atlas on risk factors for multiple sclerosis: a mendelian randomization study</article-title>. <source>J Neurol</source> (<year>2021</year>) <volume>268</volume>(<issue>1</issue>):<page-range>114&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00415-020-10119-8</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neufer</surname> <given-names>PD</given-names>
</name>
<name>
<surname>Bamman</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Muoio</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Bouchard</surname> <given-names>C</given-names>
</name>
<name>
<surname>Cooper</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Goodpaster</surname> <given-names>BH</given-names>
</name>
<etal/>
</person-group>. <article-title>Understanding the cellular and molecular mechanisms of physical activity-induced health benefits</article-title>. <source>Cell Metab</source> (<year>2015</year>) <volume>22</volume>(<issue>1</issue>):<fpage>4</fpage>&#x2013;<lpage>11</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cmet.2015.05.011</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharif</surname> <given-names>K</given-names>
</name>
<name>
<surname>Watad</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bragazzi</surname> <given-names>NL</given-names>
</name>
<name>
<surname>Lichtbroun</surname> <given-names>M</given-names>
</name>
<name>
<surname>Amital</surname> <given-names>H</given-names>
</name>
<name>
<surname>Shoenfeld</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Physical activity and autoimmune diseases: Get moving and manage the disease</article-title>. <source>Autoimmun Rev</source> (<year>2018</year>) <volume>17</volume>(<issue>1</issue>):<fpage>53</fpage>&#x2013;<lpage>72</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.autrev.2017.11.010</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Surakka</surname> <given-names>J</given-names>
</name>
<name>
<surname>Romberg</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ruutiainen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Aunola</surname> <given-names>S</given-names>
</name>
<name>
<surname>Virtanen</surname> <given-names>A</given-names>
</name>
<name>
<surname>Karppi</surname> <given-names>SL</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of aerobic and strength exercise on motor fatigue in men and women with multiple sclerosis: a randomized controlled trial</article-title>. <source>Clin Rehabil</source> (<year>2004</year>) <volume>18</volume>(<issue>7</issue>):<page-range>737&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1191/0269215504cr780oa</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swank</surname> <given-names>C</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>M</given-names>
</name>
<name>
<surname>Medley</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Aerobic exercise in people with multiple sclerosis: its feasibility and secondary benefits</article-title>. <source>Int J MS Care</source> (<year>2013</year>) <volume>15</volume>(<issue>3</issue>):<page-range>138&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.7224/1537-2073.2012-037</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barry</surname> <given-names>A</given-names>
</name>
<name>
<surname>Cronin</surname> <given-names>O</given-names>
</name>
<name>
<surname>Ryan</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Sweeney</surname> <given-names>B</given-names>
</name>
<name>
<surname>Yap</surname> <given-names>SM</given-names>
</name>
<name>
<surname>O&#x2019;Toole</surname> <given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>Impact of exercise on innate immunity in multiple sclerosis progression and symptomatology</article-title>. <source>Front Physiol</source> (<year>2016</year>) <volume>7</volume>:<elocation-id>194</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphys.2016.00194</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gleeson</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bishop</surname> <given-names>NC</given-names>
</name>
<name>
<surname>Stensel</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Lindley</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Mastana</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Nimmo</surname> <given-names>MA</given-names>
</name>
</person-group>. <article-title>The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease</article-title>. <source>Nat Rev Immunol</source> (<year>2011</year>) <volume>11</volume>(<issue>9</issue>):<page-range>607&#x2013;15</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri3041</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kr&#xfc;ger</surname> <given-names>K</given-names>
</name>
<name>
<surname>Mooren</surname> <given-names>FC</given-names>
</name>
<name>
<surname>Pilat</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>The immunomodulatory effects of physical activity</article-title>. <source>Curr Pharm design</source> (<year>2016</year>) <volume>22</volume>(<issue>24</issue>):<page-range>3730&#x2013;48</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/1381612822666160322145107</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>White</surname> <given-names>LJ</given-names>
</name>
<name>
<surname>Castellano</surname> <given-names>V</given-names>
</name>
</person-group>. <article-title>Exercise and brain health&#x2013;implications for multiple sclerosis: Part II&#x2013;immune factors and stress hormones</article-title>. <source>Sports Med (Auckland NZ)</source> (<year>2008</year>) <volume>38</volume>(<issue>3</issue>):<page-range>179&#x2013;86</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2165/00007256-200838030-00001</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>White</surname> <given-names>LJ</given-names>
</name>
<name>
<surname>Castellano</surname> <given-names>V</given-names>
</name>
</person-group>. <article-title>Exercise and brain health&#x2013;implications for multiple sclerosis: Part 1&#x2013;neuronal growth factors</article-title>. <source>Sports Med (Auckland NZ)</source> (<year>2008</year>) <volume>38</volume>(<issue>2</issue>):<fpage>91</fpage>&#x2013;<lpage>100</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2165/00007256-200838020-00001</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>